Diabetic Eye Disease

Latest News

Image Credit: © Seventyfour - stock.adobe.com
Alimera completes recruitment for its NEW DAY study

May 25th 2023

According to the company, the study has now reached its goal of 300 patients enrolled to evaluate ILUVIEN as a first line, baseline therapy for DME.

This week in optometry: March 20-March 24
This week in optometry: March 20-March 24

March 25th 2023

Do diabetes, diabetic retinal disease contribute to macular degeneration?
Do diabetes, diabetic retinal disease contribute to macular degeneration?

March 21st 2023

row of syringes of aflibercept
Regeneron receives FDA acceptance, priority review of BLA for aflibercept 8 mg for wet AMD and DME

February 23rd 2023

Surprising findings from the DRCR Retina Network Protocol AA
Surprising findings from the DRCR Retina Network Protocol AA

January 23rd 2023

Video Series
Video Interviews
Podcasts
Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye!
Open Your Eyes with Dr Kerry Gelb featuring Dr. Jay Haynie in "diabetes of the eye"
Latest CME Events & Activities

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Ophthalmology Consultations™: Keeping an Eye Out for MGD-Associated Dry Eye in Pre/Post-Op Patients – Improving Surgical Outcomes by Optimizing the Surface

View More

Community Practice Connections™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

View More

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

View More

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

Cases & Conversations™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

View More

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

View More

More News

© 2023 MJH Life Sciences

All rights reserved.